360º retinectomy effective for retinal detachment

Article

Virectomy with 360º retinectomy can be beneficial for the treatment of complex retinal detachments

It has been demonstrated that virectomy with 360º retinectomy can be beneficial for the treatment of complex retinal detachments, from recent research published in Retina.

Dr Anton Kolomeyer et al., Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey, USA, reviewed the data of 41 eyes of 40 patients who underwent pars plana virectomy and 360º retinectomy for various reasons.

For 26 of the 41 eyes the main reason for surgery was retinal detachment after penetrating trauma. The outcome measures were complete retinal reattachment or attachment posterior to the scleral buckle. It was found that 11 eyes had recurrent retinal detachment and 7 received repeat pars plana virectomy with success in 6 of the eyes. The treatment was an anatomical success in 25 of 30 eyes and only 4 of the eyes had limited visual results.

The results show complex retinal detachment can be sufficiently managed by virectomy with 360º retinectomy.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.